Who
Bruce C. Robertson
Director
Company insider
Files Form 4 as: Director, Exagen; Director, RxSight; Director and 10% owner, Lpath.
In numbers
- Trades disclosed
- 14
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 29 Dec 2016
- Last trade
- 9 Jun 2026
- Last filed
- 24 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jun 2026filed 24 Aug 2026 | XGN Exagenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 9 Jun 2026filed 24 Aug 2026 | XGN Exagenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 9 Jun 2026filed 19 Aug 2026 | XGN Exagenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 9 Jun 2026filed 19 Aug 2026 | XGN Exagenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 3 Aug 2021filed 5 Aug 2021 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code C | —968,054 at $0.00 | filing |
| 3 Aug 2021filed 5 Aug 2021 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code C | —403,355 at $0.00 | filing |
| 3 Aug 2021filed 5 Aug 2021 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code M | —60,503 at $0.00 | filing |
| 3 Aug 2021filed 5 Aug 2021 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code M | —60,503 at $0.00 | filing |
| 3 Aug 2021filed 5 Aug 2021 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code F | —46,875 at $0.00 | filing |
| 3 Aug 2021filed 5 Aug 2021 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code C | —13,628 at $0.00 | filing |
| 3 Aug 2021filed 5 Aug 2021 | RXST RxSightMedical Devices | SEC FORM 4 Code C | —1,385,037 at $0.00 | filing |
| 17 Jun 2021filed 21 Jun 2021 | XGN Exagenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —9,000 at $0.00 | filing |
| 18 Jun 2020filed 16 Jul 2020 | XGN Exagenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —9,000 at $0.00 | filing |
| 29 Dec 2016filed 30 Dec 2016 | Lpath | SEC FORM 4 Code J | —1,451,185 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.